Cumberland Pharmaceuticals Inc. Net Fee Amt
Cumberland Pharmaceuticals Inc. (CPIX) had Net Fee Amt of $13.81 thousand as of 2026-05-14, per its PREM14A filed 2026-05-15.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-05-15
- 2026-05-14: Net Fee Amt $13.81K.
| Period end | Net Fee Amt |
|---|---|
| 2026-05-14 | $13.81K PREM14A · filed 2026-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |